Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

The complexity of TNF-related apoptosis-inducing ligand.

Abe K, Kurakin A, Mohseni-Maybodi M, Kay B, Khosravi-Far R.

Ann N Y Acad Sci. 2000;926:52-63. Review.

PMID:
11193041
2.

Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.

Siegmund D, Mauri D, Peters N, Juo P, Thome M, Reichwein M, Blenis J, Scheurich P, Tschopp J, Wajant H.

J Biol Chem. 2001 Aug 31;276(35):32585-90. Epub 2001 May 30.

3.

Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.

Harper N, Hughes MA, Farrow SN, Cohen GM, MacFarlane M.

J Biol Chem. 2003 Nov 7;278(45):44338-47. Epub 2003 Aug 14.

4.
5.

TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.

Uno K, Inukai T, Kayagaki N, Goi K, Sato H, Nemoto A, Takahashi K, Kagami K, Yamaguchi N, Yagita H, Okumura K, Koyama-Okazaki T, Suzuki T, Sugita K, Nakazawa S.

Blood. 2003 May 1;101(9):3658-67. Epub 2002 Dec 27.

6.

Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

Song JH, Bellail A, Tse MC, Yong VW, Hao C.

J Neurosci. 2006 Mar 22;26(12):3299-308. Erratum in: J Neurosci. 2006 May 3;26(18):4983.

7.

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.

MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, Cohen GM.

Oncogene. 2002 Oct 3;21(44):6809-18.

8.

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.

Cell Death Differ. 2004 Jul;11 Suppl 1:S86-96.

9.

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.

Suliman A, Lam A, Datta R, Srivastava RK.

Oncogene. 2001 Apr 19;20(17):2122-33.

10.

Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP.

Hietakangas V, Poukkula M, Heiskanen KM, Karvinen JT, Sistonen L, Eriksson JE.

Mol Cell Biol. 2003 Feb;23(4):1278-91.

11.

Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.

Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, J├ęgou B, Patard JJ, Guillaudeux T.

Prostate. 2006 Jun 15;66(9):987-95.

PMID:
16541419
12.

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy.

Almasan A, Ashkenazi A.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):337-48. Review.

PMID:
12787570
13.

Mechanisms of resistance to TRAIL-induced apoptosis in cancer.

Zhang L, Fang B.

Cancer Gene Ther. 2005 Mar;12(3):228-37. Review.

PMID:
15550937
14.
15.

TRAIL, a mighty apoptosis inducer.

Kim Y, Seol DW.

Mol Cells. 2003 Jun 30;15(3):283-93. Review.

16.

Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells.

Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP.

Blood. 2002 Mar 15;99(6):2162-71.

17.

TRAIL-induced signalling and apoptosis.

MacFarlane M.

Toxicol Lett. 2003 Apr 4;139(2-3):89-97. Review.

PMID:
12628743
18.
19.

Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.

Aggarwal BB, Bhardwaj U, Takada Y.

Vitam Horm. 2004;67:453-83. Review.

PMID:
15110190
20.

Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis.

Higuchi H, Yoon JH, Grambihler A, Werneburg N, Bronk SF, Gores GJ.

J Biol Chem. 2003 Jan 3;278(1):454-61. Epub 2002 Oct 28.

Items per page

Supplemental Content

Write to the Help Desk